FIELD: medicine, gastroenterology.
SUBSTANCE: invention proposes a preparation containing 5-aminosalicylic acid or a substance converting to 5-aminosalicylic acid in body, and lyophilized dried bacterial mass of live bifidobacteria or lactobacilli or their mixture wherein bacteria can be immobilized on sorbent. Components of the preparation are placed into two capsules wherein one capsule comprises bacterial mass of live bacteria and another one comprises mesalazine or sulfasalazine. Proposed invention provides the enhanced effectiveness in treatment of noninfectious inflammatory intestine diseases and reducing treatment period using the proposed preparation. Invention can be used in treatment of noninfectious inflammatory intestine diseases.
EFFECT: valuable medicinal properties of preparation, enhanced effectiveness of treatment.
9 cl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT WITH VITAMIN D3 FOR TREATING ULCERATIVE COLITIS IN THE FORM OF RECTAL SUPPOSITORIES | 2019 |
|
RU2709209C1 |
| MELATONIN AGENT FOR TREATING INFLAMMATORY BOWEL DISEASES IN THE FORM OF RECTAL SUPPOSITORIES | 2023 |
|
RU2819721C1 |
| RECTAL POLYCOMPLEX GEL FOR TREATMENT OF ULCERATIVE COLITIS, CROHN'S DISEASE, FISTULAS AND COMPLICATIONS CAUSED BY THESE DISEASES | 2014 |
|
RU2605615C2 |
| RECTAL SUPPOSITORIES, HAVING ANTI-INFLAMMATORY, ANTIOXIDANT, IMMUNOSTIMULATING ACTION, CONTAINING RHIZOMES WITH COMMON TURMERIC ROOTS | 2020 |
|
RU2743427C1 |
| METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES | 2009 |
|
RU2394571C1 |
| METHOD OF TREATING PATIENTS WITH ULCERATIVE COLITIS | 2009 |
|
RU2419443C1 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INFLAMMATORY INTESTINAL DISEASES (IID) | 2010 |
|
RU2561040C2 |
| PRODUCT WITH GRANULES CONTAINING 5-AMINOSALICYLIC ACID AND FOLIC ACID WITH CONTROLLED RELEASE | 2020 |
|
RU2752082C1 |
| DYSBACTERIOSIS TREATMENT AGENT AND A METHOD FOR PREPARATION THEREOF | 2002 |
|
RU2221582C2 |
| IMMUNOBIOLOGICAL AGENT BASED ON BUTYRATE AND THE METHOD FOR ITS USE FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | 2021 |
|
RU2780868C1 |
